Cited by 1,635T-cell and B-cell ImmunologyImmunotherapy and Immune ResponsesImmune responses and vaccinations

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

Janssen, Edith M., Lemmens, Edward E., Wolfe, Tom, Christen, Urs, von Herrath, Matthias G., Schoenberger, Stephen P.·2003·Nature

DOI 10.1038/nature01441

Open this paper in CoChat — free account

Abstract

A long-standing paradox in cellular immunology concerns the conditional requirement for CD4+ T-helper (T(H)) cells in the priming of cytotoxic CD8+ T lymphocyte (CTL) responses in vivo. Whereas CTL responses against certain viruses can be primed in the absence of CD4+ T cells, others, such as those mediated through 'cross-priming' by host antigen-presenting cells, are dependent on T(H) cells. A clearer understanding of the contribution of T(H) cells to CTL development has been hampered by the fact that most T(H)-independent responses have been demonstrated ex vivo as primary cytotoxic effectors, whereas T(H)-dependent responses generally require secondary in vitro re-stimulation for their detection. Here, we have monitored the primary and secondary responses of T(H)-dependent and T(H)-independent CTLs and find in both cases that CD4+ T cells are dispensable for primary expansion of CD8+ T cells and their differentiation into cytotoxic effectors. However, secondary CTL expansion (that is, a secondary response upon re-encounter with antigen) is wholly dependent on the presence of T(H) cells during, but not after, priming. Our results demonstrate that T-cell help is 'programmed' into CD8+ T cells during priming, conferring on these cells a hallmark of immune response memory: the capacity for functional expansion on re-encounter with antigen.

Integrity signals

Registry

Crossref · 10.1038/nature01441

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Self-citation
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Rosa, F. D., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,360
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,091
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Immunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · cited 1×
“Although transition through these stages was thought to be governed by the presence and eventual elimination of antigen, mounting evidence suggests that CD8 p T-cell development is guided by an instructional programme that, once set into motion during priming, is executed independentl”
Background
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
Dialynas, D. P., Quan, Z., Wall, K. A., Pierrès, A., Quintáns, J., Loken, M. R., Pierres, M., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2445 · Cited by 1,273
Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells
Kaech, S. M., & Ahmed, R. (2001) · Nature Immunology · doi:10.1038/87720 · Cited by 1,265
Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation
van Stipdonk, M. J. B., Lemmens, E. E., & Schoenberger, S. P. (2001) · Nature Immunology · doi:10.1038/87730 · Cited by 843
Self-citation
T Cell-Dependent B Cell Activation
Parker, D. C. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001555 · Cited by 739

Flagged first, then by citations

Show all 28 references

Sorted by citations

Items 201–300 of 1,000

Bovine Herpesvirus Type 1 (BHV-1) is an Important Cofactor in the Bovine Respiratory Disease Complex
Jones, C., & Chowdhury, S. I. (2010) · Veterinary Clinics of North America Food Animal Practice · doi:10.1016/j.cvfa.2010.04.007 · Cited by 144
An innately interesting decade of research in immunology
Germain, R. N. (2004) · Nature Medicine · doi:10.1038/nm1159 · Cited by 136
Adoptive Cell Therapy for Patients with Melanoma, Using Tumor-Infiltrating Lymphocytes Genetically Engineered to Secrete Interleukin-2
Heemskerk, B., Liu, K., Dudley, M. E., Johnson, L. A., Kaiser, A., Downey, S. G., Zheng, Z., Shelton, T. E., Matsuda, K. M., Robbins, P. F., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.0171 · Cited by 136
The CD8 Population in CD4-deficient Mice Is Heavily Contaminated with MHC Class II–restricted T Cells
Tyznik, A. J., Sun, J. C.-Y., & Bevan, M. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031961 · Cited by 136
CD4 T Cell-Dependent CD8 T Cell Maturation
Khanolkar, A., Fuller, M. J., & Zajac, A. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2834 · Cited by 136
Distinct Roles for IL-2 and IL-15 in the Differentiation and Survival of CD8+ Effector and Memory T Cells
Mitchell, D. M., Ravkov, E. V., & Williams, M. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904089 · Cited by 140
Compartmentalization of Simian Immunodeficiency Virus Replication within Secondary Lymphoid Tissues of Rhesus Macaques Is Linked to Disease Stage and Inversely Related to Localization of Virus-Specific CTL
Connick, E., Folkvord, J. M., Lind, K. T., Rakasz, E. G., Miles, B., Wilson, N. A., Santiago, M. L., Schmitt, K. P., Stephens, E. B., Kim, H. O., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401161 · Cited by 135
Soluble Form of T Cell Ig Mucin 3 Is an Inhibitory Molecule in T Cell-Mediated Immune Response
Geng, H., Zhang, G., Li, D., Zhang, H., Yuan, Y., Zhu, H.-G., Han, X., Han, L., & Feng, Z. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1411 · Cited by 136
Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 Expression
Lo, D. J., Weaver, T. A., Stempora, L., Mehta, A. K., Ford, M. L., Larsen, C. P., & Kirk, A. D. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03317.x · Cited by 134
CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities
Ahrends, T., Busselaar, J., Severson, T., Bąbała, N., de Vries, E., Bovens, A. A., Wessels, L. F. A., van Leeuwen, F., & Borst, J. G. (2019) · Nature Communications · doi:10.1038/s41467-019-13438-1 · Cited by 133
Heterogeneity of CD4+ and CD8+ T cells
Woodland, D. L., & Dutton, R. W. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00037-2 · Cited by 132
Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4+- and CD8+-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV-Positive Nasopharyngeal Carcinoma
Taylor, G. S., Haigh, T. A., Gudgeon, N. H., Phelps, R. J., Lee, S. P., Steven, N. M., & Rickinson, A. B. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.768-778.2004 · Cited by 132
Recall Proliferation Potential of Memory CD8+ T Cells and Antiviral Protection
Bachmann, M. F., Wolint, P., Schwarz, K., & Oxenius, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4677 · Cited by 131
Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
Noubade, R., Majri-Morrison, S. S., & Tarbell, K. V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01014 · Cited by 134
Prospects for an AIDS vaccine: three big questions, no easy answers
Garber, D. A., Silvestri, G., & Feinberg, M. B. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01056-4 · Cited by 130
Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys
Liu, J., Ewald, B. A., Lynch, D. M., Denholtz, M., Abbink, P., Lemckert, A. A. C., Carville, A., Mansfield, K. G., Havenga, M. J. E., Goudsmit, J., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02616-07 · Cited by 129
CD4+T-Cell Responses to Epstein-Barr Virus (EBV) Latent-Cycle Antigens and the Recognition of EBV-Transformed Lymphoblastoid Cell Lines
Long, H. M., Haigh, T. A., Gudgeon, N. H., Leen, A. M., Tsang, C.-W., Brooks, J. M., Landais, E., Houssaint, E., Lee, S. P., Rickinson, A. B., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.4896-4907.2005 · Cited by 129
CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity
Calzascia, T., Pellegrini, M., Lin, A., Garza, K. M., Elford, A. R., Shahinian, A., Ohashi, P. S., & Mak, T. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712135105 · Cited by 129
CD8 T Cells Remember with a Little Help
Kaech, S. M., & Ahmed, R. (2003) · Science · doi:10.1126/science.1084511 · Cited by 127
Immune memory redefined: characterizing the longevity of natural killer cells
Sun, J. C.-Y., Beilke, J. N., & Lanier, L. L. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00900.x · Cited by 126
Cutting Edge: A Critical Role for CD70 in CD8 T Cell Priming by CD40-Licensed APCs
Taraban, V. Y., Rowley, T. F., & Al‐Shamkhani, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6542 · Cited by 125
Dynamic Regulation of CD8 T Cell Tolerance Induction by Liver Sinusoidal Endothelial Cells
Schurich, A., Berg, M., Stabenow, D., Böttcher, J., Kern, M., Schild, H.-J., Kurts, C., Schuette, V., Burgdorf, S., Diehl, L., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902580 · Cited by 124
Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy
Berlin, C., Kowalewski, D. J., Schuster, H., Mirza, N., Walz, J. S., Handel, M., Schmid-Horch, B., Salih, H. R., Kanz, L., Rammensee, H., et al. (2014) · Leukemia · doi:10.1038/leu.2014.233 · Cited by 129
Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion
Kaartinen, T., Luostarinen, A., Maliniemi, P., Keto, J., Arvas, M., Belt, H., Koponen, J., Loskog, A., Mustjoki, S. M., Porkka, K., et al. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.03.067 · Cited by 126
Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo
Antony, P. A., Paulos, C. M., Ahmadzadeh, M., Akpınarlı, A., Palmer, D. C., Sato, N., Kaiser, A., Hinrichs, C. S., Klebanoff, C. A., Tagaya, Y., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5255 · Cited by 130
Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals
Cosma, A., Nagaraj, R., Bühler, S., Hinkula, J., Busch, D. H., Sutter, G., Goebel, F. D., & Erfle, V. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00538-3 · Cited by 124
Fully Functional Memory CD8 T Cells in the Absence of CD4 T Cells
Marzo, A. L., Vezys, V., Klonowski, K. D., Lee, S., Muralimohan, G., Moore, M. W., Tough, D. F., & Lefrançois, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.969 · Cited by 123
The present status and future prospects of peptide-based cancer vaccines
Hirayama, M., & Nishimura, Y. (2016) · International Immunology · doi:10.1093/intimm/dxw027 · Cited by 128
Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses
Hugues, S., Scholer, A., Boissonnas, A., Nussbaum, A. K., Combadière, C., Amigorena, S., & Fetler, L. (2007) · Nature Immunology · doi:10.1038/ni1495 · Cited by 127
Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies
Rezvani, K., Yong, A. S. M., Mielke, S., Jafarpour, B., Savani, B. N., Le, R., Eniafe, R. B., Musse, L., Boss, C., Kurlander, R. J., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.031674 · Cited by 121
The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer
Khazaie, K., & von Boehmer, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.11.006 · Cited by 121
DNA vaccines to attack cancer
Stevenson, F. K., Ottensmeier, C. H. H., Johnson, P., Zhu, D., Buchan, S. L., McCann, K. J., Roddick, J. S., King, A. T., McNicholl, F. P., Savelyeva, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404896101 · Cited by 121
Tapping CD4 T Cells for Cancer Immunotherapy: The Choice of Personalized Genomics
Zanetti, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402669 · Cited by 133
The CD4+ T-cell help signal is transmitted from APC to CD8+ T-cells via CD27–CD70 interactions
Feau, S., Garcia, Z., Arens, R., Yagita∥, H., Borst, J. G., & Schoenberger, S. P. (2012) · Nature Communications · doi:10.1038/ncomms1948 · Cited by 124
Self-citation
A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens
Swaminathan, G., Thoryk, E. A., Cox, K. S., Meschino, S., Dubey, S. A., Vora, K. A., Celano, R., Gindy, M. E., Casimiro, D. R., & Bett, A. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.132 · Cited by 118
The role of CD4 T cell help for CD8 CTL activation
Zhang, S., Zhang, H., & Zhao, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.134 · Cited by 127
Helper T cells, dendritic cells and CTL Immunity
Behrens, G. M. N., Li, M., Smith, C. M., Belz, G. T., Mintern, J. D., Carbone, F., & Heath, W. R. (2004) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2004.01211.x · Cited by 118
T cell homeostasis: Keeping useful T cells alive and live T cells useful
Jameson, S. C. (2005) · Seminars in Immunology · doi:10.1016/j.smim.2005.02.003 · Cited by 118
From crucial to negligible: Functional CD 8+ T ‐cell responses and their dependence on CD 4+ T ‐cell help
Wiesel, M., & Oxenius, A. (2012) · European Journal of Immunology · doi:10.1002/eji.201142205 · Cited by 123
Functional Dichotomy between OX40 and 4-1BB in Modulating Effector CD8 T Cell Responses
Lee, S., Park, Y., Song, A., Cheroutre, H., Kwon, B. S., & Croft, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4464 · Cited by 120
4-1BB and OX40 Dual Costimulation Synergistically Stimulate Primary Specific CD8 T Cells for Robust Effector Function
Lee, S., Myers, L. M., Muralimohan, G., Dai, J., Qiao, Y., Li, Z., Mittler, R. S., & Vella, A. T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3002 · Cited by 117
New approaches from nanomedicine for treating leishmaniasis
Gutiérrez, V., Seabra, A. B., Reguera, R. M., Khandare, J. J., & Calderón, M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00674k · Cited by 120
T cell responses to Listeria monocytogenes
Lara-Tejero, M. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.12.002 · Cited by 116
Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation
Micklethwaite, K. P., Clancy, L. E., Sandher, U., Hansen, A. M., Blyth, E., Antonenas, V., Sartor, M. M., Bradstock, K. F., & Gottlieb, D. J. (2008) · Blood · doi:10.1182/blood-2008-06-161695 · Cited by 116
Long-Lived Poxvirus Immunity, Robust CD4 Help, and Better Persistence of CD4 than CD8 T Cells
Amara, R. R., Nigam, P., Sharma, S., Liu, J., & Boštíková, V. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.3811-3816.2004 · Cited by 117
Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene
Frelin, L., Ahlén, G., Alheim, M., Weiland, O., Barnfield, C., Liljeström, P., & Sällberg, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302184 · Cited by 114
Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection
Moeller, M., Haynes, N. M., Kershaw, M. H., Jackson, J. T., Teng, M. W. L., Street, S. E. A., Cerruti, L., Jane, S. M., Trapani, J. A., Smyth, M. J., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4906 · Cited by 114
Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics
Breckpot, K., Aerts, J. L., & Thielemans, K. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302947 · Cited by 115
An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy
Lal, N., Beggs, A. D., Willcox, B. E., & Middleton, G. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.976052 · Cited by 116
Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
Sutherland, S., Ju, X., Horvath, L. G., & Clark, G. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641307 · Cited by 115
An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response
Steenblock, E. R., Fadel, T. R., Labowsky, M. J., Pober, J. S., & Fahmy, T. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276329 · Cited by 113
Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
Kyte, J. A., Gaudernack, G., Dueland, S., Trachsel, S., Julsrud, L., & Aamdal, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0184 · Cited by 111
Defective Th1 Cytokine Gene Transcription in CD4+ and CD8+ T Cells from Wiskott-Aldrich Syndrome Patients
Trifari, S., Sitia, G., Aiuti, A., Scaramuzza, S., Marangoni, F., Guidotti, L. G., Martino, S., Saracco, P., Notarangelo, L. D., Roncarolo, M., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7451 · Cited by 111
Identification of T-cell epitopes for cancer immunotherapy
Kessler, J. H., & Melief, C. J. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404787 · Cited by 113
Role of CD8+ T lymphocytes in control of Mycobacterium tuberculosis infection
Grotzke, J. E., & Lewinsohn, D. M. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.03.001 · Cited by 110
Th1 memory: implications for vaccine development
Foulds, K. E., Wu, C. Y., & Seder, R. A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00400.x · Cited by 110
Expanding Roles for CD4 T Cells and Their Subpopulations in Tumor Immunity and Therapy
Dobrzanski, M. J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00063 · Cited by 116
T Cell Immunity in Acute HIV‐1 Infection
Streeck, H., & Nixon, D. F. (2010) · The Journal of Infectious Diseases · doi:10.1086/655652 · Cited by 106
Stimulation by Soluble CD70 Promotes Strong Primary and Secondary CD8+ Cytotoxic T Cell Responses In Vivo
Rowley, T. F., & Al‐Shamkhani, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6039 · Cited by 106
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses
Barouch, D. H., Letvin, N. L., & Seder, R. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00200.x · Cited by 106
CD4 T cells in tumor immunity
Gerloni, M., & Zanetti, M. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0193-z · Cited by 106
Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection
van Leeuwen, E. M. M., Remmerswaal, E. B. M., Heemskerk, M. H. M., ten Berge, I. J. M., & van Lier, R. A. W. (2006) · Blood · doi:10.1182/blood-2006-03-006809 · Cited by 106
The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy
Walz, S., Stickel, J. S., Kowalewski, D. J., Schuster, H., Weisel, K. C., Backert, L., Kahn, S., Nelde, A., Bilich, T., Handel, M., et al. (2015) · Blood · doi:10.1182/blood-2015-04-640532 · Cited by 112
Complement C5a Receptor Is Essential for the Optimal Generation of Antiviral CD8+ T Cell Responses
Kim, A. H. J., Dimitriou, I. D., Holland, M. C., Mastellos, D. C., Mueller, Y. M., Altman, J. D., Lambris, J. D., & Katsikis, P. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2524 · Cited by 105
Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection
Duvall, M. G., Jaye, A., Dong, T., Brenchley, J. M., Alabi, A. S., Jeffries, D. J., van der Sande, M. A. B., Togun, T. O., McConkey, S. J., Douek, D. C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6973 · Cited by 105
Enhancing immune responses by targeting antigen to DC
Caminschi, I., Lahoud, M. H., & Shortman, K. (2009) · European Journal of Immunology · doi:10.1002/eji.200839035 · Cited by 111
Deliberate removal of T cell help improves virus-neutralizing antibody production
Recher, M., Lang, K. S., Hunziker, L., Freigang, S., Eschli, B., Harris, N. L., Navarini, A. A., Senn, B. M., Fink, K., Lötscher, M., et al. (2004) · Nature Immunology · doi:10.1038/ni1102 · Cited by 103
Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination
Stern, P. L. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.005 · Cited by 103
Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components
Lin, T.-J., Lin, H.-T., Chang, W.-T., Pradeep Mitapalli., S., Hsiao, P., Yin, S., & Yang, N. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0435-9 · Cited by 103
Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells
Srivastava, M. K., Bosch, J. J., Thompson, J. A., Ksander, B. R., Edelman, M. J., & Ostrand‐Rosenberg, S. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0490-9 · Cited by 102
Intrinsic IL-21 Signaling Is Critical for CD8 T Cell Survival and Memory Formation in Response to Vaccinia Viral Infection
Novy, P., Huang, X., Leonard, W. J., & Yang, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003009 · Cited by 105
IL-7 Receptor Expression Levels Do Not Identify CD8+ Memory T Lymphocyte Precursors following Peptide Immunization
Lacombe, M.-H., Hardy, M., Rooney, J., & Labrecque, N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4400 · Cited by 102
Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model
Yoon, S. H., Lee, J. M., Cho, H. I., Kim, E. K., Kim, H. S., Park, M. Y., & Kim, T. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.98 · Cited by 102
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
Kowalczyk, A., Doener, F., Zanzinger, K., Noth, J., Baumhof, P., Fotin-Mleczek, M., & Heidenreich, R. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.05.046 · Cited by 101
Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8+ T cell responses
Si, Y., Wen, Y., Kelly, S. H., Chong, A. S., & Collier, J. H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.031 · Cited by 101
Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses
Rocha, B., & Tanchot, C. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.03.004 · Cited by 101
Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice
Lim, W. H., Kireta, S., Russ, G. R., & Coates, P. T. H. (2006) · Blood · doi:10.1182/blood-2005-12-024802 · Cited by 101
CD4 T Lymphocytes: A Critical Component of Antitumor Immunity
Ostrand‐Rosenberg, S. (2005) · Cancer Investigation · doi:10.1081/cnv-200067428 · Cited by 106
Combinatorial Immunotherapy of Polyinosinic–Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors
Nagato, T., Lee, Y.-R., Harabuchi, Y., & Celis, E. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2781 · Cited by 103
Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells
Liadi, I., Singh, H., Romain, G., Rey-Villamizar, N., Merouane, A., Adolacion, J. R. T., Kebriaei, P., Huls, H. M., Qiu, P., Roysam, B., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0195 · Cited by 102
Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma
Packiriswamy, N., Upreti, D., Zhou, Y., Khan, R., Miller, A. C., Díaz, R. M., Rooney, C. M., Dispenzieri, A. A., Peng, K.-W., & Russell, S. J. (2020) · Leukemia · doi:10.1038/s41375-020-0828-7 · Cited by 100
CD4 T Cells Promote CD8 T Cell Immunity at the Priming and Effector Site during Viral Encephalitis
Phares, T. W., Stohlman, S. A., Hwang, M., Min, B., Hinton, D. R., & Bergmann, C. C. (2011) · Journal of Virology · doi:10.1128/jvi.06797-11 · Cited by 103
Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses
Kaliński, P., & Moser, M. (2005) · Nature reviews. Immunology · doi:10.1038/nri1569 · Cited by 99
Memory T-Cell Heterogeneity and TerminologyPreprint
Muroyama, Y., & Wherry, E. J. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037929 · Cited by 104
Microfluidic squeezing for intracellular antigen loading in polyclonal B-cells as cellular vaccines
Szeto, G. L., Egeren, D. V., Worku, H. A., Sharei, A., Alejandro, B. S., Park, C., Frew, K., Brefo, M. S. N., Mao, S., Heimann, M., et al. (2015) · Scientific Reports · doi:10.1038/srep10276 · Cited by 100
Mucosal immunology of HIV infection
Xu, H., Wang, X., & Veazey, R. S. (2013) · Immunological Reviews · doi:10.1111/imr.12072 · Cited by 102
Chronic Human Infection with Trypanosoma cruzi Drives CD4+ T Cells to Immune Senescence
Albareda, M. C., Olivera, G. C., Laucella, S. A., Alvarez, M. G., Fernández, E. R., Lococo, B., Viotti, R. J., Tarleton, R. L., & Postan, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900852 · Cited by 98
Cutting Edge: CD4+ T Cell-Derived IL-2 Is Essential for Help-Dependent Primary CD8+ T Cell Responses
Wilson, E. B., & Livingstone, A. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7445 · Cited by 98
Generation of Antifungal Effector CD8+ T Cells in the Absence of CD4+ T Cells during Cryptococcus neoformans Infection
Lindell, D. M., Moore, T. A., McDonald, R. A., Toews, G. B., & Huffnagle, G. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7920 · Cited by 98
T Cell Immunity to Bacterial Pathogens: Mechanisms of Immune Control and Bacterial Evasion
Shepherd, F. R., & McLaren, J. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176144 · Cited by 101
Human Dendritic Cell Subsets for Vaccination
Dubsky, P. C., Ueno, H., Piqueras, B., Connolly, J., Banchereau, J., & Palucka, K. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-8216-7 · Cited by 100
Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
Tao, Z., Chyra, Z., Kotulová, J., Celichowski, P., Mihályová, J., Charvátová, S., & Hájek, R. (2024) · Blood Cancer Journal · doi:10.1038/s41408-024-01193-6 · Cited by 101
Cutting Edge: Long-Lived CD8 Memory and Protective Immunity in the Absence of CD40 Expression on CD8 T Cells
Sun, J. C.-Y., & Bevan, M. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3385 · Cited by 96
Cancer vaccination with telomerase peptide GV1001
Kyte, J. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902897631 · Cited by 95
Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell Responses
Moutaftsi, M., Bui, H., Peters, B., Sidney, J., Salek‐Ardakani, S., Oseroff, C., Pasquetto, V., Crotty, S., Croft, M., Lefkowitz, E. J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6814 · Cited by 94
Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy
Zuazo, M., Arasanz, H., Bocanegra, A., Fernández, G., Chocarro, L., Vera, R., Kochan, G. T., & Escors, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586907 · Cited by 97
HIV Patients Developing Primary CNS Lymphoma Lack EBV-Specific CD4+ T Cell Function Irrespective of Absolute CD4+ T Cell Counts
Gasser, O., Bihl, F. K., Wolbers, M., Loggi, E., Steffen, I., Hirsch, H. H., Günthard, H. F., Walker, B. D., Brander, C., Battegay, M., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040096 · Cited by 94
CD4 + T cells support cytotoxic T lymphocyte priming by controlling lymph node input
Kumamoto, Y., Mattei, L. M., Sellers, S., Payne, G. W., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100567108 · Cited by 95
Improving Outcomes for Solid-Organ Transplant Recipients At Risk from Cytomegalovirus Infection: Late-Onset Disease and Indirect Consequences
Legendre, C., & Pascual, M. A. (2008) · Clinical Infectious Diseases · doi:10.1086/527397 · Cited by 94
T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes
Juedes, A. E., Rodrigo, E., Togher, L. M., Glimcher, L. H., & von Herrath, M. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031873 · Cited by 94

Authors: Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P.
Affiliations: La Jolla Institute for Immunology (US)
Corresponding author: Schoenberger, Stephen P.
ORCID: Janssen, Edith M.
Lemmens, Edward E.
Christen, Urs
Schoenberger, Stephen P.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2003-02
Volume: 421
Issue: 6925
Pages: 852-856
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature01441
OpenAlex: W1493822493
Cited by: 1,635
References: 28
Citations by year: 2026: 19 · 2025: 24 · 2024: 37 · 2023: 46 · 2022: 37 · 2021: 42 · 2020: 58 · 2019: 42 · 2018: 52 · 2017: 36 · 2016: 41 · 2015: 61 · 2014: 63 · 2013: 63 · 2012: 71
FWCI: 46.09
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Institutes of Health
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords: CD4+ T cells, CD8+ T cells, cytotoxic T lymphocytes, T helper cells, secondary immune response, T cell memory, T cell help, cross-priming, antigen-presenting cells, T cell differentiation
MeSH terms: Animals, Antigens, Cell Line, Cytotoxicity, Immunologic, Flow Cytometry, T-Lymphocytes, Helper-Inducer, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, T-Lymphocytes, Cytotoxic, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks